Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Galecto, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GLTO
Nasdaq
2830
galecto.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Galecto, Inc.
Galecto Reports First Quarter 2025 Operating and Financial Results
- May 8th, 2025 2:30 pm
Galecto Reports Full-Year 2024 Financial Results
- Mar 19th, 2025 2:45 pm
Galecto to Participate in Upcoming Investor Conferences
- Feb 6th, 2025 6:00 am
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- Nov 14th, 2024 7:55 am
Galecto Reports Third Quarter 2024 Financial Results
- Nov 1st, 2024 6:30 am
Galecto price target raised to $10 from $9 at Oppenheimer
- Oct 18th, 2024 6:15 am
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
- Oct 15th, 2024 6:30 am
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines
- Oct 7th, 2024 6:45 am
Galecto Announces Reverse Stock Split
- Aug 28th, 2024 7:00 am
Scroll